Tri-component copolymer rods as an implantable reservoir drug delivery system for constant and controllable drug release rate

Journal of Polymer Research

Volumn 19, Issue 12, 2012, Pages

  Chanlen, Tararat ^a,c   Hongeng, Suradej ^b   Nasongkla, Norased ^a,c  

^a Mahidol University   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Biodegradable polymers; Controllable drug release rate; Drug delivery systems; Polymer rods; Reservoir drug delivery system

Indexed keywords

BIODEGRADABLE POLYMERS; HYDROPHILICITY; ORGANIC POLYMERS; POLYETHYLENE GLYCOLS; POLYMERIC IMPLANTS; RESERVOIRS (WATER);

CONTROLLABLE DRUG RELEASE; CONTROLLED DRUG RELEASE; CONTROLLED THICKNESS; DRUG DELIVERY SYSTEM; HYDROLYSIS RATE; POLYMER RODS; WATER-SOLUBLE MOLECULE; ZERO-ORDER RELEASE;

CONTROLLED DRUG DELIVERY;

EID: 84870065711     PISSN: 10229760     EISSN: 15728935     Source Type: Journal    
DOI: 10.1007/s10965-012-0036-x     Document Type: Article

References (37)

1. Gliadel wafers for treatment of brain tumors (1998) Med Lett Drugs Ther 40(1035):92
2. Qian F, Nasongkla N, Gao J (2002) Membrane-encased polymer millirods for sustained release of 5-fluorouracil. J Biomed Mater Res 61(2):203-211
3. Qian F, Szymanski A, Gao J (2001) Fabrication and characterization of controlled release poly(D, L-lactide-co-glycolide) millirods. J Biomed Mater Res 55(4):512-522
4. Weinberg BD, Ai H, Blanco E, Anderson JM, Gao J (2007) Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res Part A 81A(1):161-170
5. Khamlao W, Hongeng S, Sakdapipanich J, Nasongkla N (2012) Preparation of self-solidifying polymeric depots from PLEC-PEGPLEC triblock copolymers as an injectable drug delivery system. J Polym Res 19(3):1-12
6. Manaspon C, Hongeng S, Boongird A, Nasongkla N (2012) Preparation and in vitro characterization of SN-38-Loaded, selfforming polymeric depots as an injectable drug delivery system. J Pharm Sci 101(10):3708-3717
7. Boongird A, Nasongkla N, Hongeng S, Sukdawong N, Sa-Nguanruang W, Larbcharoensub N (2011) Biocompatibility study of glycofurol in rat brains. Exp Biol Med (Maywood, NJ) 236(1):77-83
8. Baker RW (1987) In: Controlled release of biologically active agents. Wiley, New York
9. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin SF, Sherry AD, Boothman DA, Gao J (2006) Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 6(11):2427-2430
10. Wang Z, Wang S, Guidoin R, Marois Y, Zhang Z (2006) In vitro homogeneous and heterogeneous degradation of poly(-caprolactone/polyethylene glycol/L-lactide): the absence of autocatalysis and the role of enzymes. J Biomed Mater Res Part A 79A(1):6-15
11. Ge H, Hu Y, Jiang X, Cheng D, Yuan Y, Bi H, Yang C (2002) Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(ε-caprolactone)-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles. J Pharm Sci 91(6):1463-1473
12. Shogren R (1997) Water vapor permeability of biodegradable polymers. J Polym Environ 5(2):91-95
13. Pearce EM, Schaefgen JR (1977) Contemporary topics in polymer science, vol 2. Plenum, New York
14. Meidong L, Jianzhong B, Shenguo W (1999) Synthesis and characterization of polycaprolactone/poly(ethylene oxide)/polylactide tricomponent copolymers. J Biomater Sci Polym Ed 10(4):501-512
15. Nasongkla N, Boongird A, Hongeng S, Manaspon C, Larbcharoensub N (2012) Preparation and biocompatibility study of in situ forming polymer implants in rat brains. JMater SciMater Med 23(2):497-505. doi:10.1007/s10856-011-4520-3
16. Hu Y, Jiang X, Ding Y, Zhang L, Yang C, Zhang J, Chen J, Yang Y (2003) Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials 24(13):2395-2404
17. Huang M-H, Li S, Vert M (2004) Synthesis and degradation of PLA-PCL-PLA triblock copolymer prepared by successive polymerization of ε-caprolactone and dl-lactide. Polymer 45(26):8675-8681. doi:10.1016/j.polymer.2004.10.054
18. Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharm-Drug Res 67(3):217-223
19. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15(1):25-35
20. Rich J, Jaakkola T, Tirri T, Närhi T, Yli-Urpo A, Seppälä J (2002) In vitro evaluation of poly(epsilon-caprolactone-co-DL-lactide)/bioactive glass composites. Biomaterials 23(10):2143-2150
21. Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH (2004) Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-bpoly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 96(1):135-148
22. Zhang Y, Wang C, Yang W, Shi B, Fu S (2005) Tri-component diblock copolymers of poly(ethylene glycol)-poly(ε-caprolactoneco -lactide): synthesis, characterization and loading camptothecin. Colloid Polym Sci 283(11):1246-1252
23. Mallapragada SK, Peppas NA, Colombo P (1997) Crystal dissolution-controlled release systems. II. Metronidazole release from semicrystalline poly(vinyl alcohol) systems. J Biomed Mater Res 36(1):125-130
24. Miyajima M, Koshika A, Ji O, Ikeda M, Nishimura K (1997) Effect of polymer crystallinity on papaverine release from poly (l-lactic acid) matrix. J Control Release 49(2-3):207-215
25. Bramfeldt H, Sarazin P, Vermette P (2007) Characterization, degradation, and mechanical strength of poly(D, L-lactide-co- -caprolactone)-poly(ethylene glycol)-poly(D, L-lactide-co- -caprolactone). J Biomed Mater Res Part A 83A(2):503-511
26. Li S (1999) Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomed Mater Res 48(3):342-353
27. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y (2000) Utilization of poly(dl-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression. J Control Release 67(1):29-36
28. Valle L, Camps R, Díaz A, Franco L, Rodríguez-Galán A, Puiggalí J (2011) Electrospinning of polylactide and polycaprolactone mixtures for preparation of materials with tunable drug release properties. J Polym Res 18(6):1903-1917
29. Babazadeh M, Edjlali L, Rashidian L (2007) Application of 2-hydroxyethyl methacrylate polymers in controlled release of 5-aminosalicylic acid as a colon-specific drug. J Polym Res 14(3):207-213
30. Jonnalagadda S, Robinson DH (2000) A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery. AAPS PharmSciTech 1(4):26-34
31. Tunón Å, Börjesson E, Frenning G, Alderborn G (2003) Drug release from reservoir pellets compacted with some excipients of different physical properties. Eur J Pharm Sci 20(4-5):469-479
32. Cai K, Yao K, Lin S, Yang Z, Li X, Xie H, Qing T, Gao L (2002) Poly(D, L-lactic acid) surfaces modified by silk fibroin: effects on the culture of osteoblast in vitro. Biomaterials 23(4):1153-1160
33. Tiaw KS, Goh SW, Hong M, Wang Z, Lan B, Teoh SH (2005) Laser surface modification of poly(ε-caprolactone) (PCL) membrane for tissue engineering applications. Biomaterials 26(7):763-769
34. Sharp JS, Forrest JA, Jones RAL (2001) Swelling of Poly(dllactide) and Polylactide-co-glycolide in humid environments. Macromolecules 34(25):8752-8760
35. Bei J, Wang W, Wang Z, Wang S (1996) Surface properties and drug release behavior of polycaprolactone polyether blend and copolymer. Polym Adv Technol 7(2):104-107
36. Sutton D, Wang S, Nasongkla N, Gao J, Dormidontova EE (2007) Doxorubicin and β-Lapachone release and interaction with micellar core materials: experiment and modeling. Exp Biol Med 232(8):1090-1099
37. Rothen-Weinhold A, Besseghir K, Gurny R (1997) Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue. Eur J Pharm Sci 5(6):303-313